Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
International Journal of Oncology
Join Editorial Board Propose a Special Issue
Print ISSN: 1019-6439 Online ISSN: 1791-2423
Journal Cover
December 2012 Volume 41 Issue 6

Full Size Image

Cover Legend PDF

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
December 2012 Volume 41 Issue 6

Full Size Image

Cover Legend PDF

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

CD82 inhibits canonical Wnt signalling by controlling the cellular distribution of β-catenin in carcinoma cells

  • Authors:
    • Satomi Chigita
    • Tsuyoshi Sugiura
    • Masakazu Abe
    • Yosuke Kobayashi
    • Miyuki Shimoda
    • Megumi Onoda
    • Kanemitsu Shirasuna
  • View Affiliations / Copyright

    Affiliations: Division of Maxillofacial Diagnostic and Surgical Sciences, Department of Oral and Maxillofacial Surgery, Graduate School of Dental Science, Kyushu University, Higashi-ku, Fukuoka 812-8582, Japan
    Copyright: © Chigita et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].
  • Pages: 2021-2028
    |
    Published online on: October 17, 2012
       https://doi.org/10.3892/ijo.2012.1671
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

We have recently unravelled a novel function for CD82 in E-cadherin-mediated cellular adhesion. CD82 inhibits β-catenin tyrosine phosphorylation and stabilizes E-cadherin-β-catenin complexes at the cell membrane. This function inhibits cancer cell dissociation from the primary cancer nest and limits metastasis. In this study, we focused on the effect of CD82 on the Wnt/β-catenin (canonical) pathway, which controls the cellular distribution of β-catenin. CD82 had no effect on the expression of Wnt proteins but led to significant downregulation of Frizzled (Fzd) 2, 3, 5, 7 and 9, suggesting downregulation of the Wnt/β-catenin pathway. CD82 also inhibited phosphorylation of β-catenin at Ser45, Ser33, Ser37 and Thr41 by downregulation of glycogen synthase kinase-3β (GSK-3β) and kinase casein kinase 1α (CK1α). Downregulation of GSK-3β and CK1α also led to accumulation of β-catenin in the cytoplasm or at the cell membrane. CD82 translocated β-catenin to the cell membrane, suggesting that CD82 strengthens the interaction between E-cadherin and β-catenin. We concluded that CD82 attenuates Wnt signalling by controlling β-catenin cellular distribution at multiple levels: i) inhibition of β-catenin nuclear translocation by downregulation of Fzd receptor proteins; ii) accumulation of β-catenin at the cell membrane by downregulation of GSK-3β and CK1α; and iii) stabilization of the E-cadherin-β-catenin complex.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1. 

M TakeichiCadherins: a molecular family important in selective cell-cell adhesionAnnu Rev Biochem59237252199010.1146/annurev.bi.59.070190.0013212197976

2. 

R KemlerFrom cadherins to catenins: cytoplasmic protein interactions and regulation of cell adhesionTrends Genet9317321199310.1016/0168-9525(93)90250-L8236461

3. 

PA PiepenhagenWJ NelsonDefining E-cadherin-associated protein complexes in epithelial cells: plakoglobin, beta- and gamma-catenin are distinct componentsJ Cell Sci1047517621993

4. 

A NagafuchiS TsukitaM TakeichiTransmembrane control of cadherin-mediated cell-cell adhesionSemin Cell Biol4175181199310.1006/scel.1993.10218347834

5. 

M TakeichiThe cadherin cell adhesion receptor family: roles in multicellular organization and neurogenesisProg Clin Biol Res39014515319947724643

6. 

H SembG ChristoforiThe tumor-suppressor function of E-cadherinAm J Hum Genet6315881593199810.1086/3021739837810

7. 

Y DokiH ShiozakiH TaharaCorrelation between E-cadherin expression and invasiveness in vitro in a human esophageal cancer cell lineCancer Res533421342619938324752

8. 

H OkaH ShiozakiK KobayashiExpression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasisCancer Res531696170119938453644

9. 

MH YangCL ChenGY ChauComprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinomaHepatology5014641474200910.1002/hep.2322119821482

10. 

DI BellovinRC BatesA MuzikanskyDL RimmAM MercurioAltered localization of p120 catenin during epithelial to mesenchymal transition of colon carcinoma is prognostic for aggressive diseaseCancer Res651093810945200510.1158/0008-5472.CAN-05-194716322241

11. 

G HanSL LuAG LiW HeCL CorlessM Kulesz-MartinXJ WangDistinct mechanisms of TGF-beta1-mediated epithelial-to-mesenchymal transition and metastasis during skin carcinogenesisJ Clin Invest11517141723200510.1172/JCI2439915937546

12. 

J BehrensJP von KriesM KuhlL BruhnD WedlichR GrosschedlW BirchmeierFunctional interaction of beta-catenin with the transcription factor LEF-1Nature382638642199610.1038/382638a08757136

13. 

O HuberR KornJ McLaughlinM OhsugiBG HerrmannR KemlerNuclear localization of beta-catenin by interaction with transcription factor LEF-1Mech Dev59310199610.1016/0925-4773(96)00597-78892228

14. 

M MolenaarM van de WeteringM OosterwegelXTcf-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryosCell86391399199610.1016/S0092-8674(00)80112-98756721

15. 

TC HeAB SparksC RagoIdentification of c-MYC as a target of the APC pathwayScience2811509151219989727977

16. 

O TetsuF McCormickBeta-catenin regulates expression of cyclin D1 in colon carcinoma cellsNature398422426199910.1038/1888410201372

17. 

PJ Morinbeta-catenin signaling and cancerBioessays2110211030199910.1002/(SICI)1521-1878(199912)22:1%3C1021::AID-BIES6%3E3.0.CO;2-P10580987

18. 

P PolakisWnt signaling and cancerGenes Dev14183718512000

19. 

D WuW PanGSK3: a multifaceted kinase in Wnt signalingTrends Biochem Sci35161168201010.1016/j.tibs.2009.10.00219884009

20. 

C LiuY LiM SemenovControl of beta-catenin phosphorylation/degradation by a dual-kinase mechanismCell108837847200210.1016/S0092-8674(02)00685-211955436

21. 

RL DaughertyCJ GottardiPhospho-regulation of Beta-catenin adhesion and signaling functionsPhysiology22303309200710.1152/physiol.00020.200717928543

22. 

J HeasmanA CrawfordK GoldstoneOverexpression of cadherins and underexpression of beta-catenin inhibit dorsal mesoderm induction in early Xenopus embryosCell79791803199410.1016/0092-8674(94)90069-87528101

23. 

RT CoxC KirkpatrickM PeiferArmadillo is required for adherens junction assembly, cell polarity, and morphogenesis during Drosophila embryogenesisJ Cell Biol134133148199610.1083/jcb.134.1.1338698810

24. 

F FagottoN FunayamaU GluckBM GumbinerBinding to cadherins antagonizes the signaling activity of beta-catenin during axis formation in XenopusJ Cell Biol13211051114199610.1083/jcb.132.6.11058601588

25. 

T SugiuraF BerditchevskiFunction of alpha3beta1-tetraspanin protein complexes in tumor cell invasion. Evidence for the role of the complexes in production of matrix metalloproteinase 2 (MMP–2)J Cell Biol14613751389199610491398

26. 

F BerditchevskiE OdintsovaCharacterization of integrintetraspanin adhesion complexes: role of tetraspanins in integrin signalingJ Cell Biol146477492199910.1083/jcb.146.2.47710427099

27. 

S Lebel-BinayML GilC LagaudriereFurther characterization of CD82/IA4 antigen (type III surface protein): an activation/differentiation marker of mononuclear cellsCell Immunol154468483199410.1006/cimm.1994.1092

28. 

JT DongPW LambCW Rinker-SchaefferJ VukanovicT IchikawaJT IsaacsJC BarrettKAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2Science268884886199510.1126/science.77543747754374

29. 

M AdachiT TakiT KonishiCI HuangM HigashiyamaM MiyakeNovel staging protocol for non-small-cell lung cancers according to MRP-1/CD9 and KAI1/CD82 gene expressionJ Clin Oncol161397140619989552043

30. 

X GuoH FriessHU GraberM KashiwagiA ZimmermannM KorcMW BuchlerKAI1 expression is up-regulated in early pancreatic cancer and decreased in the presence of metastasesCancer Res564876488019968895737

31. 

M TakahashiT SugiuraK ShirasunaTetraspanin CD82/KAI-1 regulates growth factor induced cancer cell migration by forming complexes with growth factor receptorsInt J Oral Maxillofac Surg34146200510.1016/S0901-5027(05)81459-6

32. 

E OdintsovaT SugiuraF BerditchevskiAttenuation of EGF receptor signaling by a metastasis suppressor, the tetraspanin CD82/KAI-1Curr Biol1010091012200010.1016/S0960-9822(00)00652-710985391

33. 

M AbeT SugiuraM TakahashiK IshiiM ShimodaK ShirasunaA novel function of CD82/KAI-1 on E-cadherin-mediated homophilic cellular adhesion of cancer cellsCancer Lett266163170200810.1016/j.canlet.2008.02.05818395972

34. 

P BhanotM BrinkCH SamosA new member of the frizzled family from Drosophila functions as a Wingless receptorNature382225230199610.1038/382225a08717036

35. 

JT WinstonP StrackP Beer-RomeroCY ChuSJ ElledgeJW HarperThe SCFbeta-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IkappaBalpha and beta-catenin and stimulates IkappaBalpha ubiquitination in vitroGenes Dev13270283199910.1101/gad.13.3.270

36. 

F PalaciosJS TushirY FujitaC D’Souza-SchoreyLysosomal targeting of E-cadherin: a unique mechanism for the down-regulation of cell-cell adhesion during epithelial to mesenchymal transitionsMol Cell Biol25389402200510.1128/MCB.25.1.389-402.200515601859

37. 

CH LeeHW HungPH HungYS ShiehEpidermal growth factor receptor regulates beta-catenin location, stability, and transcriptional activity in oral cancerMol Cancer964201010.1186/1476-4598-9-6420302655

38. 

F VerkaarGJ ZamanA model for signaling specificity of Wnt/Frizzled combinations through co-receptor recruitmentFEBS Lett58438503854201010.1016/j.febslet.2010.08.03020800062

39. 

TL LeAS YapJL StowRecycling of E-cadherin: a potential mechanism for regulating cadherin dynamicsJ Cell Biol146219232199910.1083/jcb.146.1.21910402472

40. 

AI IvanovA NusratCA ParkosEndocytosis of epithelial apical junctional proteins by a clathrin-mediated pathway into a unique storage compartmentMol Biol Cell15176188200410.1091/mbc.E03-05-031914528017

41. 

A ChairoungduaDL SmithP PochardM HullMJ CaplanExosome release of beta-catenin: a novel mechanism that antagonizes Wnt signalingJ Cell Biol19010791091201010.1083/jcb.20100204920837771

42. 

H YamamotoN OueA SatoWnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinaseOncogene2920362046201010.1038/onc.2009.49620101234

43. 

A SatoH YamamotoH SakaneH KoyamaA KikuchiWnt5a regulates distinct signalling pathways by binding to Frizzled2EMBO J294154201010.1038/emboj.2009.32219910923

44. 

S MatsumotoK FumotoT OkamotoK KaibuchiA KikuchiBinding of APC and dishevelled mediates Wnt5a-regulated focal adhesion dynamics in migrating cellsEMBO J2911921204201010.1038/emboj.2010.2620224554

45. 

YW ZhangYF MiaoJ YiJ GengR WangLB ChenTranscriptional inactivation of secreted frizzled-related protein 1 by promoter hypermethylation as a potential biomarker for non-small cell lung cancerNeoplasma57228233201010.4149/neo_2010_03_22820353273

46. 

J WillertM EppingJR PollackPO BrownR NusseA transcriptional response to Wnt protein in human embryonic carcinoma cellsBMC Dev Biol28200210.1186/1471-213X-2-812095419

47. 

B LustigB JerchowM SachsNegative feedback loop of Wnt signaling through upregulation of conductin/axin2 in colorectal and liver tumorsMol Cell Biol2211841193200210.1128/MCB.22.4.1184-1193.200211809809

48. 

J RooseG HulsM van BeestSynergy between tumor suppressor APC and the beta-catenin-Tcf4 target Tcf1Science28519231926199910.1126/science.285.5435.192310489374

49. 

M FilaliN ChengD AbbottV LeontievJF EngelhardtWnt-3A/beta-catenin signaling induces transcription from the LEF-1 promoterJ Biol Chem2773339833410200210.1074/jbc.M10797720012052822

50. 

M TakahashiT SugiuraM AbeK IshiiK ShirasunaRegulation of c-Met signaling by the tetraspanin KAI-1/CD82 affects cancer cell migrationInt J Cancer12119191929200710.1002/ijc.2288717621632

51. 

S Dupre-CrochetA FigueroaC HoganCasein kinase 1 is a novel negative regulator of E-cadherin-based cell-cell contactsMol Cell Biol2738043816200710.1128/MCB.01590-0617353278

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Chigita S, Sugiura T, Abe M, Kobayashi Y, Shimoda M, Onoda M and Shirasuna K: CD82 inhibits canonical Wnt signalling by controlling the cellular distribution of β-catenin in carcinoma cells. Int J Oncol 41: 2021-2028, 2012.
APA
Chigita, S., Sugiura, T., Abe, M., Kobayashi, Y., Shimoda, M., Onoda, M., & Shirasuna, K. (2012). CD82 inhibits canonical Wnt signalling by controlling the cellular distribution of β-catenin in carcinoma cells. International Journal of Oncology, 41, 2021-2028. https://doi.org/10.3892/ijo.2012.1671
MLA
Chigita, S., Sugiura, T., Abe, M., Kobayashi, Y., Shimoda, M., Onoda, M., Shirasuna, K."CD82 inhibits canonical Wnt signalling by controlling the cellular distribution of β-catenin in carcinoma cells". International Journal of Oncology 41.6 (2012): 2021-2028.
Chicago
Chigita, S., Sugiura, T., Abe, M., Kobayashi, Y., Shimoda, M., Onoda, M., Shirasuna, K."CD82 inhibits canonical Wnt signalling by controlling the cellular distribution of β-catenin in carcinoma cells". International Journal of Oncology 41, no. 6 (2012): 2021-2028. https://doi.org/10.3892/ijo.2012.1671
Copy and paste a formatted citation
x
Spandidos Publications style
Chigita S, Sugiura T, Abe M, Kobayashi Y, Shimoda M, Onoda M and Shirasuna K: CD82 inhibits canonical Wnt signalling by controlling the cellular distribution of β-catenin in carcinoma cells. Int J Oncol 41: 2021-2028, 2012.
APA
Chigita, S., Sugiura, T., Abe, M., Kobayashi, Y., Shimoda, M., Onoda, M., & Shirasuna, K. (2012). CD82 inhibits canonical Wnt signalling by controlling the cellular distribution of β-catenin in carcinoma cells. International Journal of Oncology, 41, 2021-2028. https://doi.org/10.3892/ijo.2012.1671
MLA
Chigita, S., Sugiura, T., Abe, M., Kobayashi, Y., Shimoda, M., Onoda, M., Shirasuna, K."CD82 inhibits canonical Wnt signalling by controlling the cellular distribution of β-catenin in carcinoma cells". International Journal of Oncology 41.6 (2012): 2021-2028.
Chicago
Chigita, S., Sugiura, T., Abe, M., Kobayashi, Y., Shimoda, M., Onoda, M., Shirasuna, K."CD82 inhibits canonical Wnt signalling by controlling the cellular distribution of β-catenin in carcinoma cells". International Journal of Oncology 41, no. 6 (2012): 2021-2028. https://doi.org/10.3892/ijo.2012.1671
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team